{"disease":{"id":"neuromyelitis-optica-spectrum-disorder-attack","name":"neuromyelitis optica spectrum disorder attack"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT07410039","title":"Therapy in the Acute Phase of NMOSD: A Multicenter Prospective Real-World Study","phase":"PHASE4","overall_status":"RECRUITING","enrollment_count":200,"lead_sponsor_name":"Chinese PLA General Hospital","has_results":false},{"nct_id":"NCT05605951","title":"Acute Optic Neuritis Network: an International Study That Invesitages Subjects With a First-ever Episode of Acute Inflammation of the Optic Nerve","phase":"","overall_status":"UNKNOWN","enrollment_count":200,"lead_sponsor_name":"Experimental and Clinical Research Center, a cooperation between the Max Delbrück Center for Molecul","has_results":false},{"nct_id":"NCT04131764","title":"Diagnosis of ON With or Without MS or NMOSD","phase":"","overall_status":"TERMINATED","enrollment_count":112,"lead_sponsor_name":"Jagannadha R Avasarala","has_results":false},{"nct_id":"NCT07184840","title":"Eculizumab For the Acute Attack of Neuromyelitis Optica Spectrum Disorder","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":110,"lead_sponsor_name":"Tianjin Medical University General Hospital","has_results":false},{"nct_id":"NCT06673394","title":"Eculizumab For Acute Attack of Neuromyelitis Optica Spectrum Disorder","phase":"PHASE2","overall_status":"WITHDRAWN","enrollment_count":0,"lead_sponsor_name":"Tianjin Medical University General Hospital","has_results":false}],"total":5},"guidelines":[],"source":"Drug Landscape verified database"}